• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Fresh2 Group Limited

    7/24/24 4:01:19 PM ET
    $FRES
    Medical Specialities
    Health Care
    Get the next $FRES alert in real time by email
    6-K 1 ea0209849-6k_fresh2.htm REPORT OF FOREIGN PRIVATE ISSUER

     

     

    U.S. SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

    THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of July 2024

     

    Commission File Number: 001-39137

     

    Fresh2 Group Limited

     

    880 3RD AVE FL 7

    NEW YORK, NY 10022-4730

    United States

    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F  ☒     Form 40-F  ☐

     

     

     

     

     

     

    CHANGES IN REGISTRANTS' CERTIFYING ACCOUNTANT

      

    (a) Dismissal of Certifying Accountant

     

    Effective July 23, 2024, the Registrant dismissed its independent auditors, Marcum Asia CPAs LLP (“Marcum Asia”), which action was approved by the Registrant’s Board of Directors on July 11, 2024.

     

    Friedman LLP (“Friedman”) the Company’s prior independent registered public accounting firm, combined with Marcum LLP effective September 21, 2022 and continued to operate as the Company’s independent registered public accounting firm through January 11, 2023. On January 12, 2023, the audit committee of the board of directors of the Company approved the engagement of Marcum Asia to serve as the independent registered public accounting firm of the Company.

     

    The reports of Friedman and Marcum Asia on the consolidated financial statements of the Company for the fiscal years ended December 31, 2021 and December 31, 2022, respectively, did not contain any adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, scope of accounting principles, except that such reports expressed doubt regarding the Company’s ability to continue as a going concern.

     

    Furthermore, during the Company’s two most recent fiscal years and through July 23, 2024, there were no disagreements with Marcum Asia and Friedman on any matters of accounting principles or practices, financial statement disclosure or auditing scope which, if not resolved to the satisfaction of Marcum Asia and Friedman, would have caused Marcum Asia and Friedman to make reference to such matters in their reports.

     

    For the period from January 12, 2023, the date of Marcum Asia’s appointment as our independent registered public accounting firm, through July 23, 2024, except for the material weaknesses in internal control reported by management in Item 15 of the Company’s Form 20-F filed with U.S. Securities and Exchange Commission (the “SEC”) on May 16, 2023, there were no other reportable events (as that term is described in Item 304(a)(1)(v) of Regulation S-K).

     

    The Company provided Marcum Asia with a copy of the forgoing disclosure and requested Marcum Asia to furnish the Company with a letter addressed to the SEC stating whether or not Marcum Asia agrees with the above statements. A copy of Marcum Asia’s letter, dated July 24, 2024, is filed as Exhibit 16.1 to this Form 6-K.

     

    (b) Engagement of New Certifying Accountant

     

    On July 19, 2024, the Registrant engaged WWC, P.C. as the Registrant’s independent auditors for the fiscal year ended December 31, 2023.

     

    During the two most recent fiscal years and in the subsequent period through July 2024, the Company has not consulted with WWC with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that would have been rendered on the Company’s consolidated financial statements, or any other matters set forth in Item 304(a)(2)(i) or (ii) of Regulation S-K.

     

    A copy of the letter of Marcum Asia to the U.S. Securities and Exchange Commission dated July 24, 2024 is filed herewith as Exhibit 16.1.

     

    Financial Statements and Exhibits

     

    Exhibit No   Description
    16.1   Letter of Marcum Asia dated July 24, 2024, regarding change in independent registered public accounting firm.

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: July 24, 2024 Fresh2 Group Limited
       
      By: /s/ Haohan Xu
      Name:  Haohan Xu
      Title: Chief Executive Officer

     

     

    2

     

     

    Get the next $FRES alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FRES
    SEC Filings

    View All

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    12/23/24 4:02:53 PM ET
    $FRES
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    11/14/24 4:15:32 PM ET
    $FRES
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    7/24/24 4:01:19 PM ET
    $FRES
    Medical Specialities
    Health Care

    $FRES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing

    New York, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or the "Company"), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on October 16, 2024, it received a Staff Determination Letter from the Nasdaq Stock Market LLC ("Nasdaq")  indicating that the Company did not comply with Nasdaq's filing requirements as set forth in Listing Rule 5250(c)(1). The letter is a result of the Company's failure to file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, and June 30, 2024, within the required deadlines. Nasdaq had previously granted

    10/17/24 4:05:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq

    New York, NY, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or the "Company"), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on August 19 , 2024, it received an additional delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising they have not received the Company's Form 10-Q for the period ended June 30, 2024, it does not comply with the Listing Rules 5250(c)(1) (the "Rules"), which requires the timely filing of all required periodic reports with the SEC. Previously, Nasdaq Staff had granted the Company an exception

    8/22/24 4:05:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Announces Collaboration with Over 50 Influencers in Video E-commerce

    New York, NY, July 16, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that its video e-commerce business has partnered with over 50 influencers, resulting in continued rapid sales growth. By leveraging these key partnerships, Fresh2's video e-commerce business is rapidly expanding its market presence in the e-commerce sector. (Screenshot of some Company's venues at tiktok) The Power of Video E-commerce Unlike traditional e-commerce, video e-commerce uses multimedia formats, which offer stronger visual appeal and can hi

    7/16/24 9:15:00 AM ET
    $FRES
    Medical Specialities
    Health Care

    $FRES
    Leadership Updates

    Live Leadership Updates

    View All

    Appointment of New Independent Director

    NEW YORK, Dec. 15, 2023 /PRNewswire/ -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced the appointment of Zhijun (Michael) Liang, as an independent director of the Company, effective January 1, 2024. Zhijun (Michael) Liang, has spent more than two decades providing management consulting and investment management services, primarily to start-ups and growth businesses, enabling them to address expansion needs and financial challenges. He co-founded Beijing Yuantong Funds Management Co., Ltd., and has led its risk and investment management since 2018. Concurrently, as the

    12/15/23 4:01:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Group Ltd. Appoints New Chief Strategy Officer to Drive Advancement and Execution of Long-Term Growth Strategy

    NEW YORK, July 26, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ:FRES) ("Fresh2," the "Company" or "we"), a company with operations in the United States and China focused on the business-to-business e-commerce and supply chain sectors for the restaurant supply and food industry and on early cancer screening and detection,  today announced the appointment of Mr. Yidong Hu as its Chief Strategy Officer (CSO) effective on July 21, 2023. Mr. Hu was appointed to drive the advancement and execution of the Company's long-term strategy. Mr. Hu is a seasoned executive with over a decade of experience in the media and finance sectors. Mr.Hu has served as

    7/26/23 9:00:00 AM ET
    $FRES
    Medical Specialities
    Health Care